Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICE Pilot RCT of dexmedetomidine-based sedation in mechanically ventilated intensive care patients
ACTRN12611000166976Phase 3Not yet recruiting
- Sponsor
- Australia and New Zealand Intensive Care Research Centre
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine in sedation (2 arms), sponsored by Australia and New Zealand Intensive Care Research Centre. Primary endpoint: Cumulative and daily administered dexmedetomidine and midazolam dose. Planned start Apr 2011; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on ACTRN12611000166976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000166976.